SourcingAI
Try for free
Powered by Made-in-China.com
High Quality Cefazolin Sodium for Injection From Reyoung
US$0.20-0.30
100,000 vials

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For external use

Model NO.

0.25g/0.5g/1.0g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Packaging

1/10/50vial/Box

Standard

USP/Cp/Bp

Transport Package

Box

Specification

0.25g/0.5g/1.0g

Trademark

Reyoung

Origin

No. 1 Ruiyang Road, Yiyuan County, Shandong

Key features

Broad Spectrum Indication: Treats respiratory, urinary, skin, bone infections, sepsis, and used as surgical prophylaxis.
Multiple Dosage Forms: Available in 0.25g, 0.5g, and 1g specifications for flexible medical usage.
Customizable Packaging: Packaging options include 1, 10, or 50 vials per box to suit different needs.
International Quality Standards: Meets USP, Cp, and Bp standards ensuring high pharmaceutical quality.
OEM and ODM Services: Manufacturer offers both Original Equipment Manufacturer and Original Design Manufacturer services.
Established Manufacturer: Operating since 1998 with 4950 employees and 1.08 million square meter plant area.
Fast Lead Time: Consistent 1-3 month lead time available during both peak and off-peak seasons.
Strong R&D Capability: Supported by 370 dedicated R&D engineers and advanced production machinery.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: >24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.
Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.
CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.
Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.
Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What infections does Cefazolin Sodium treat?
A:
It treats infections caused by sensitive bacteria including otitis media, bronchitis, pneumonia, urinary tract infections, skin and soft tissue infections, bone and joint infections, sepsis, and eye, ear, nose, throat infections.
Q:What are the available specifications?
A:
The product is available in 0.25g, 0.5g, and 1g specifications.
Q:Is this product suitable for central nervous system infections?
A:
No, this product is not suitable for treating central nervous system infections.
Q:Can the packaging be customized?
A:
Yes, packaging can be customized to 1, 10, or 50 vials per box.
Q:What quality standards does the product meet?
A:
The product meets USP, Cp, and Bp standards.

Send Inquiry

*To:REYOUNG PHARMACEUTICAL CO., LTD.REYOUNG PHARMACEUTICAL CO., LTD.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

Mining Reagent Sodium Sulfite From China

Mining Reagent Sodium Sulfite From China

US$2,500.00-2,700.00
1 Ton(MOQ)
Made-in-China.com
Sodium Glycolate CAS2836-32-0

Sodium Glycolate CAS2836-32-0

US$30.00
1,000 kg(MOQ)
Made-in-China.com
Refined Sodium Chloride for Pickling

Refined Sodium Chloride for Pickling

US$50.00-90.00
10 Tons(MOQ)
Made-in-China.com